When A Pitch Doesn't Go As Planned

Markus Warmuth, M.D., CEO, Monte Rosa Therapeutics, notes a previous pitching experience when he was working on some of the coolest science he had ever worked on, and there being stunned silence at the end. Fellow panelists of this executive virtual roundtable (EVR) on Pitching And Fundraising In The New Norm (view full video here), Josh Brumm, CEO of Dyne Therapeutics, and Keith Vendola, M.D., CSO and head of strategy at Rezolute, add to the conversation with some of the wisdom gained from their experiences.